BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32999132)

  • 1. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature.
    Hiruma M; Sasano Y; Watanabe N; Yoshihara A; Ishii S; Yaguchi Y; Yoshimura Noh J; Sugino K; Ito K
    Endocr J; 2021 Feb; 68(2):145-151. PubMed ID: 32999132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Tanaka R; Shimojima Y; Moteki H; Kishida D; Ueno KI; Sekijima Y
    Intern Med; 2018 Oct; 57(20):3029-3033. PubMed ID: 29780146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease.
    Aoki Y; Kitazawa K; Kobayashi H
    Paediatr Int Child Health; 2019 May; 39(2):142-145. PubMed ID: 29457989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
    Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Watanabe-Kusunoki K; Abe N; Nakazawa D; Karino K; Hattanda F; Fujieda Y; Nishio S; Yasuda S; Ishizu A; Atsumi T
    Medicine (Baltimore); 2019 Apr; 98(17):e15328. PubMed ID: 31027105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.
    Koide S; Kitajima K; Yamazaki M; Ichikawa T; Komatsu M
    Intern Med; 2023 Jul; 62(13):1951-1955. PubMed ID: 36384900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
    Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
    Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.
    Thamprajamchit S; Jariengprasert C; Rajatanavin R
    Endocr Pract; 2004; 10(5):432-7. PubMed ID: 15760792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV).
    Morita Y; Kitazawa M; Yagi C; Nonomura Y; Takahashi K; Yamagishi T; Ohshima S; Izumi S; Horii A
    Auris Nasus Larynx; 2020 Oct; 47(5):740-746. PubMed ID: 32173171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis.
    Yoshida N; Iino Y
    Allergol Int; 2014 Dec; 63(4):523-32. PubMed ID: 25339433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
    Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
    Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purpura in a young woman with hyperthyroidism].
    Giraud-Kerleroux L; Bernigaud C; Droumaguet C; Thai LH; Marciano-Fellous L; Thomas L; Charpentier C; Helbert-Davidson S; Fardet L; Hüe S; Ingen-Housz-Oro S
    Rev Med Interne; 2021 Jul; 42(7):509-512. PubMed ID: 33846035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].
    Fujii A; Arimura Y; Minoshima S; Kobayashi M; Yoshihara K; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Takahashi H
    Ryumachi; 1997 Dec; 37(6):788-93. PubMed ID: 9492566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.